Systematic reviews
Efficacy of dual HER2 blockade in neoadjuvant HER2-positive breast cancer: a meta-analysis of RCTs.
Wu Chen, Ling Yang, Ji Zhang, Ye Yuan
Published: 202610.1186/s13643-025-03058-w
Abstract
INTRODUCTION: HER2-positive breast cancer is an aggressive subtype that benefits from targeted therapies. According to the Chinese Society of Clinical Oncology (CSCO) guidelines and the National Comprehensive Cancer Network (NCCN), the combination of…
Preview only. Read the full abstract at the source